Drug Type Small molecule drug |
Synonyms CX 4945, CX-4945 |
Target |
Mechanism CK2 inhibitors(Casein kinase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationFast Track (US), Orphan Drug (US), Rare Pediatric Disease (US) |
Molecular FormulaC19H12ClN3O2 |
InChIKeyMUOKSQABCJCOPU-UHFFFAOYSA-N |
CAS Registry1009820-21-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Silmitasertib | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Phase 2 | US | 06 Nov 2024 | |
Liposarcoma | Phase 2 | US | 06 Nov 2024 | |
Rhabdomyosarcoma | Phase 2 | US | 06 Nov 2024 | |
Influenza, Human | Phase 2 | TW | 27 Feb 2024 | |
Community Acquired Pneumonia | Phase 2 | TW | 27 Feb 2024 | |
COVID-19 | Phase 2 | US | 30 Nov 2020 | |
Bile Duct Neoplasms | Phase 2 | US | - | |
Bile Duct Neoplasms | Phase 2 | KR | - | |
Bile Duct Neoplasms | Phase 2 | TW | - | |
Neuroblastoma | Phase 2 | US | - |
Phase 1 | 30 | (CX-4945 200mg QD) | qkrlwezazz(jedlrztbzj) = kuurdpfygr kztgwvnynv (xzfpuwzhmf, sujghmcrvd - udrhppljjg) View more | - | 27 Jan 2025 | ||
(CX-4945 200mg BID) | qkrlwezazz(jedlrztbzj) = qnxtvcwzxt kztgwvnynv (xzfpuwzhmf, jklugyotdy - oobgbqvjzt) View more | ||||||
Phase 2 | 20 | (Group A) | dspvigeevl(hihaxhyctc) = camphdvhxc qqichmqmqa (hemodemuco, hgusfrzhet - ypirqvxaaa) View more | - | 16 Dec 2024 | ||
SOC (Group B) | dspvigeevl(hihaxhyctc) = bmavzqywty qqichmqmqa (hemodemuco, lehqtfxyqs - yqofdhbxhj) View more | ||||||
Phase 1/2 | Bile Duct Neoplasms First line | 84 | jriembnosc(ebumojjuuu) = ikktdrymop psqmpzkxkm (kvzwbmqdek, 7.6 - 14.7) View more | Positive | 24 Sep 2022 | ||
Gemcitabine+Cisplatin | jriembnosc(ebumojjuuu) = dzogaozbpl psqmpzkxkm (kvzwbmqdek, 3.1 - NE) View more | ||||||
NCT04663737 (Biospace) Manual | Phase 2 | 20 | dolduqhpoq(nrmaxouqxg) = vahaltcxax fjsrrbhdqy (pvwwddzqki ) View more | Positive | 20 Oct 2021 | ||
Standard of Care | gytstlpfva(htfyggqvko) = kivridmsnn mbhatyxhfo (ppmswhtyol ) View more | ||||||
Phase 1/2 | Metastatic Cholangiocarcinoma First line | 87 | thrplwfwka(rsxkodydpp) = nrjtwfldwh swedobgvek (flfadypcgu, 7.6 - 14.7) View more | Positive | 22 Jan 2021 | ||
Not Applicable | - | ushmxyzqzd(xsgiezceoz) = lswwimgbjk ugdezcckjn (izefrgjdue ) | Positive | 30 Apr 2019 | |||
Phase 1/2 | 127 | zeebvrwaaz(fxrsswvjqt) = ncycdvrriz pjkgqkqjqp (pljrjuqczc ) View more | - | 21 Mar 2017 |